oncology

An immuno-oncology targeting panel accurately characterized tumor-resident immune cells and located pathologically and clinically relevant tumor microenvironment features. 

In this webinar, Christoph Herbel will discuss multiplexed spatial analyses that identify ovarian tumor antigens and CAR T cell candidates.

Industry expertise helps scientists navigate and streamline antibody-drug conjugate research and development.

Explore a cfDNA library preparation workflow that maximizes sensitivity and conversion with low sample inputs.

An expert panel will discuss mRNA-based vaccines, current approaches and challenges, and how researchers are moving RNA therapeutics forward in exciting new directions.

In this webinar, Patrick Schmidt will explore how to streamline CAR T cell product manufacturing processes for immunotherapy. 

Tumors overexpress certain genes to survive a growing pile of harmful mutations, a trait that scientists could exploit to target with drugs.

Susan Thomas discusses how her team engineered a microfluidic device to screen for T cells with improved homing capability to tumor cells. 

Andris Abramenkovs and Mark Lynch will discuss how to overcome challenges obtaining high-definition genomic data from single cells.

High-quality sample preparation, single-cell analysis, and ultra-high content spatial proteomics for multi-dimensional research workflows.

Automated liquid handling workstations offer flexibility for a wide range of application and process needs.

Learn about the advantages of high-throughput flow cytometry for antibody discovery workflows. 

New single cell technologies make previously unattainable discoveries a reality.

The Transcreener dAMP Exonuclease Assay reliably locates compounds that antagonize TREX1.

In this webinar, Shaye Hagler will discuss the unexplored capabilities of ChipCytometry^TM Spatial Multiplexing Technology for advancing spatial biology research.

Scientists discover tumor-associated T cells that drive breast cancer metastasis to lymph nodes.

In this webinar, Sandhya Sharma will discuss how to enrich for antigen-specific T-cells to treat virus-associated malignancies.

Discover how to decentralize clinical trials and assess patient health remotely.  

The announcement confirms earlier reports that Bertagnolli will become the first woman to lead the National Cancer Institute since its founding in 1937.